中国癌症杂志 ›› 2013, Vol. 23 ›› Issue (7): 481-486.doi: 10.3969/j.issn.1007-3969.2013.07.001

• 论著 • 上一篇    下一篇

Smad4静默对K-ras突变小鼠胰腺PanIN细胞增殖及转移能力的影响

齐晓光1,胡毅1,汪进良1,谈文龙2,王琪3,王立夫3,Tuveson DA4   

  1. 1.解放军总医院肿瘤综合治疗科二病区,北京 100853;
    2.上海交通大学医学院免疫研究所,上海 200025;
    3.上海交通大学医学院附属瑞金医院消化内科,上海200025;
    4.英国剑桥大学肿瘤科,剑桥CB2 ORE
  • 出版日期:2013-07-25 发布日期:2014-03-03
  • 通信作者: 王立夫 E-mail:lifuwang2010@yahoo.cn
  • 基金资助:
    国家自然科学基金(No:30672385)

Smad4 silencing on PanIN cells accelerates K-ras G12D-mediated pancreatic neoplasia

QI Xiaoguang1,HU Yi1,WANG Jin-liang1,TAN Wen-long2,WANG Qi3,WANG Li-fu3,TUVESON DA4   

  1. 1.Department of Oncology, Chinese PLA General Hospital, Beijing 100853, China;
    2. Shanghai Institute of Immunology, Shanghai Jiao Tong University, School of Medicine Shanghai 200025, China; 
    3. Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China;
    4. Cambridge Research Institute, Cancer Research UK, Cambridge CB2 ORE, UK
  • Published:2013-07-25 Online:2014-03-03
  • Contact: WANG Li-fu E-mail: lifuwang2010@yahoo.cn

摘要:

背景与目的:由己建立的小鼠基因打靶模型证实,K-ras突变启动了胰腺癌前病变—胰腺上皮内瘤变(pancreatic intraepithelial neoplasiaPanIN)p53p16失活均可单独促进小鼠PanIN发展为浸润性胰腺癌。作为人胰腺癌中另一失活频率高发的抑癌基因Smad4,本课题组前期研究提示,应用RNA干扰技术沉默PanIN细胞株中内源性Smad4表达,促使PanIN细胞恶性转化。基于此目的,本研究进一步探讨siRNA干扰Smad 4基因对PanIN细胞体内外增殖及转移能力的影响,从而有助于阐明PanIN恶性转化的新机制。方法:构建和筛选能特异性静默PanIN细胞中Smad4表达的最佳siRNA稳定表达质粒,稳定转染最佳siRNA表达质粒进入PanIN细胞,用Zeocin筛选稳定转染克隆,挑选阳性克隆、扩增,稳定转染后细胞命名为PanIN-S。本研究运用细胞计数、克隆形成实验等分别比较两组在活细胞率和体外增殖能力的影响,同时为进一步验证Smad 4基因静默对PanIN细胞体外迁移、侵袭能力的影响,本研究采用TranswellMitigel assay检测其干扰前后体外运动、侵袭能力。动物实验中,建立PanINPanIN-S细胞组裸鼠移植瘤模型,并应用免疫组化方法检测并比较两组PCNAVEGFMMP-9的表达及其差异。结果:成功构建了Smad4基因siRNA体系;体外实验中与PanIN组相比,PanIN-S组细胞增殖、侵袭能力明显增强,差异有统计学意义(P<0.05);动物模型免疫组化结果显示,与PanIN组相比,PanIN-SPCNAVEGFMMP-9表达显著增高(P<0.05)结论:K-ras突变基础上小鼠PanIN细胞Smad4基因静默促使PanIN细胞的恶性转化;PanIN基础上Smad4静默促使小鼠PanIN细胞体内外增殖及转移能力的增强,其增殖及转移可能与PCNAVEGFMMP-9高表达有关。

关键词: siRNA干扰, Smad4基因, 胰腺上皮肉瘤变细胞, 细胞增殖, 转移

Abstract:

Background and purpose: Pancreatic intraepithelial neoplasia (PanIN) may be a precursor lesion of infiltrating pancreatic ductal adenocarcinoma. The mutation of the phenotypic impact of K-ras G12D alone, silencing of p53 and p16 could promote this process. The role of Smad4 in this progression was poorly understood. In our previous studies, we investigated that RNA interference silence of Smad4 to promote the PanIN cell malignant transformation. In the present study, we investigate. The further explores the siRNA interference of Smad4 expression on PanIN cells could lead to proliferation and metastasis in vitro and in vivo. Methods: Smad4 knock-down PanIN cells (PanIN-S) were established by stable transfection with lentiviral-mediated Smad4 RNA interference. In vitro, silence of Smad4 enhanced the proliferation of PanIN cells as determined by cell counting. A soft agar assay was used to assess the anchorage-independent growth ability of cells. Cell migration and invasion assays were performed using transwell chambers with or without Matrigel. In xenograft model experiments, PCNA, VEGF and MMP-9 staining was separately used to evaluate cell proliferation and angiogenesis and migration (VEGF and MMP-9). Results: Effect of siRNA of Smad4 gene in PanIN cells was confirmed by real-time RT-PCR and western blot. In vitro, silence of Smad4 enhanced the proliferation of PanIN cells as determined by cell counting. Soft agar assay showed that there were more colony cell numbers in PanIN-S cells compared with PanIN cells (P<0.05). Using the transwell assay, we observed that PanIN-S cells migrated faster than PanIN cells and similar results were obtained by Matrigel assay (P<0.05). Furthermore, immunohistochemical analysis of the harvested tumors suggested that Smad4 silencing was associated with cell proliferation (PCNA reactivity) and angiogenesis and migration (VEGF and MMP-9), and the expressions of PCNA, VEGF and MMP-9 in PanIN-S group were significantly increased (P<0.05). Conclusion: Silence of Smad4 in PanIN cells enhanced progression to invasive adenocarcinoma of the pancreas by promoting cell growth, migration and invasion. Smad4 might be a new diagnostic marker in pancreatic cancer and prove to be a feasible and novel target for therapeutic intervention.

Key words: siRNA interference, Smad4 gene, PanIN cell, Proliferation, Migration